Happy Hippo Sold an Opioid Without Saying So. Millions of Americans Paid the Price.
A kratom company hid its products’ opioid-level addiction risks behind a smiling cartoon mascot, candy-flavored packaging, and free samples at gas stations.
Happy Hippo LLC sold kratom products at gas stations and smoke shops using colorful, cartoon-heavy packaging that made them look like candy or energy drinks. What the company never told consumers: kratom acts on the same opioid receptors in the brain as heroin and morphine, carries the same addiction and dependency risks, and produces brutal withdrawal symptoms when stopped. The company knew. It sold free samples anyway. It buried the only warning it had in a dropdown menu buried on a product page. Millions of consumers, many of whom had never heard of kratom, were left to discover they were addicted the hard way. This is not an accident. This is a business model.
Share this page. Demand warning labels on all kratom products. Support the class action plaintiffs fighting for accountability.
The Allegations: A Breakdown
| 01 | Happy Hippo sold kratom products that interact with the same opioid receptors (mu-opioid receptors) as heroin, morphine, and fentanyl, yet placed zero disclosure of this fact on product labels, packaging, or primary marketing materials. | high |
| 02 | The company deliberately framed its kratom energy shots as sugar-free, caffeine-free fitness supplements suitable for “fast-paced, active lifestyles,” using language designed to mislead consumers into equating kratom with a standard energy drink. | high |
| 03 | Happy Hippo used a brightly colored smiling hippopotamus mascot named “Puddles,” candy-inspired product names (Taffy, Huckleberry, Fruit Punch, Blood Orange), and a “Live Happy” slogan that plaintiffs allege was designed to appeal to younger consumers and suppress perception of risk. | high |
| 04 | The only addiction-related disclaimer on the website was hidden inside a dropdown menu on individual product pages, reading only that kratom “may have addictive properties.” No warning appeared on physical product packaging. | high |
| 05 | Happy Hippo offered free kratom samples through its website and authorized retail stores with no addiction warning of any kind, a tactic the complaint compares directly to street-level drug distribution. | high |
| 06 | The class action alleges violations of California’s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, breach of implied warranty, unjust enrichment, and fraud by omission on behalf of a nationwide class of purchasers. | med |
| 01 | Kratom’s active alkaloids (mitragynine and 7-hydroxymitragynine) bind to the mu-opioid receptor, the same receptor activated by morphine and heroin, producing euphoria, sedation, and analgesia at higher doses. | high |
| 02 | Kratom withdrawal symptoms mirror traditional opioid withdrawal: irritability, anxiety, depression, restless leg syndrome, muscle and bone pain, diarrhea, chills, and extreme dysphoria. | high |
| 03 | Long-term users report depression, anhedonia, anxiety, and reduced sex drive as documented consequences of sustained kratom use. | high |
| 04 | Kratom’s addiction is described as uniquely “sneaky”: because users are unaware of its opioid nature, they mistake early withdrawal symptoms for something else, then take more kratom believing company marketing claims that it will “help them feel better.” | high |
| 05 | Two-thirds of the estimated 1 million Americans who use kratom monthly do so daily, a usage pattern consistent with dependency rather than voluntary supplementation. | med |
| 06 | Because kratom remains largely unknown to mainstream consumers and lacks established recovery resources in the U.S., addicted users face a particularly isolated and under-supported path to sobriety. | high |
| 01 | Kratom’s addictive properties have been documented in scientific literature since at least 1988, and its pharmacological similarities to opioids were well-established by the time Happy Hippo was selling its products. | high |
| 02 | Happy Hippo imports some of its kratom from Thailand, a country that has studied kratom addiction for over a century and banned the substance in 1943. The company’s supply chain relationships provided direct access to this documented knowledge. | high |
| 03 | The company employs specialized labs to isolate and extract kratom alkaloids for a subset of its products, demonstrating technical knowledge of kratom’s pharmacological mechanisms while simultaneously refusing to warn consumers about them. | high |
| 04 | Happy Hippo received user reports about kratom’s addictive potential and had direct interactions with Southeast Asian growers and distributors who disclosed kratom’s addictive nature. The company chose profit over disclosure. | high |
| 05 | The complaint alleges that Happy Hippo knowingly omitted addiction warnings because it understood they were “material facts” that would harm sales, constituting fraud by omission under California and federal consumer protection law. | high |
| 01 | The kratom industry generates $1.3 billion annually in the United States. Happy Hippo participates in this revenue stream by engineering consumer ignorance rather than correcting it. | high |
| 02 | Happy Hippo’s business model depends structurally on repeat purchases driven by addiction: once users are dependent, they continue purchasing not because they want to but because stopping causes severe withdrawal symptoms. | high |
| 03 | The company’s free sample program directly expanded its customer base by introducing consumers to an addictive substance without disclosing its addictive nature, converting unsuspecting first-time users into paying customers. | high |
| 04 | Plaintiff L.S. spent $80 to $90 per month at the height of his addiction. One forum user described a $50-per-day habit maintained alongside a newborn child and a mortgage. The financial burden of kratom dependency falls entirely on the people least informed about what they were buying. | high |
| 01 | Happy Hippo marketed kratom energy shots as suitable alternatives to traditional caffeinated pre-workouts and positioned the products as tools for “acute focus, concentration, and appetite suppression,” framing an opioid-acting substance as a performance supplement. | high |
| 02 | The company promoted kratom as an herbal treatment for pain, opioid withdrawal symptoms, depression, and anxiety, making therapeutic claims for a product with no FDA approval and severe undisclosed addiction risks. | high |
| 03 | A website banner advertised “Magic Hippo” kratom under the heading “Magical Mind and Comfortable Reality” alongside benefits labeled “Discomfort Relief,” “Joyful Spirit,” and “Restful Sleep,” none of which disclosed opioid-receptor activity or addiction risk. | med |
| 04 | Happy Hippo’s “Happiness Guarantee,” bright-pink packaging, cartoon hippo mascot, and candy-inspired product names function as a coordinated branding strategy that obscures the product’s narcotic pharmacology behind a veneer of wholesome fun. | high |
| 05 | The complaint explicitly compares Happy Hippo’s youth-targeting marketing tactics to those of tobacco and vape companies whose deceptive advertising practices resulted in mass addiction among younger Americans. | high |
Timeline of Events
Direct Quotes from the Legal Record
“What reasonable consumers do not know, and what Defendant fails to disclose, is that the ‘active ingredients’ in its kratom Products are equivalent to opioids.”
💡 This establishes the core legal claim: Happy Hippo concealed the pharmacological identity of its product from the people buying it.
“Defendant relies on its Products’ vague packaging and consumers’ limited knowledge of kratom pharmacology to get unsuspecting users addicted to its Products and reaps profits from these addictions.”
💡 The complaint alleges the concealment is not negligence but strategy. The ignorance of consumers is the product.
“The Products look like a watermelon candy more than they do a hard opioid.”
💡 This is the central visual deception: packaging designed to look harmless functions as a tool of consumer fraud.
“Just like a street-level drug dealer might do, Defendant has authorized stores, and on information and belief, in some cases, instructed them, to give the Products out as free samples.”
💡 Offering free samples of a product that causes physical dependency, without disclosing that dependency risk, is alleged to be deliberate predatory conduct.
“The United States is going through an opiate crisis that is shaking the foundations of our society. Amid this crisis, Defendant is creating more addicts for no reason other than to line its pockets.”
💡 The complaint situates Happy Hippo’s conduct squarely inside the broader opioid epidemic, not as an isolated consumer protection violation but as active participation in a public health catastrophe.
“I had lost my JOB, my boyfriend, and my personality. It landed me in the hospital many times actually. I was losing hair, my eyes looked horrible, my skin was horribly dry, and I was miserable. I decided to go to REHAB. Effing rehab for this sh!t.”
💡 This is a real person describing the real cost of being deceived by a company that knew exactly what it was selling. This is not a side effect. This is the predictable outcome of selling an opioid-acting substance without warning.
“Last night may have been one of the roughest nights of my life. It felt like a bad acid trip. I got zero sleep. The RLS was so bad I kept getting out of bed… It felt like I was being electrocuted!!!”
💡 The suffering described in this user account is medically consistent with documented opioid withdrawal. Happy Hippo’s packaging said nothing about the possibility of this outcome.
“My habit was $50 a day, and with a newborn and mortgage etc I’m still trying to climb out of that hole.”
💡 Kratom addiction is not abstract. It is rent money, baby formula, and grocery budgets redirected to a company that never warned its customers this was the risk.
“What is particularly insidious about kratom, they describe, is that because they are unaware of kratom’s negative side effects and its addictive potential, when they begin to experience the negative symptoms attributable to addiction in the early stages of taking kratom products, they do not attribute it to the kratom.”
💡 This is not a warning Happy Hippo placed anywhere. Consumers had to learn it from their own bodies, after the addiction had already taken hold.
“There is a dropdown menu at the bottom of the Product page entitled ‘Kratom Use Disclaimer’ that when clicked on, reveals text stating ‘[k]ratom may have addictive properties that can cause dependency issues.'”
💡 “May have addictive properties” buried in a dropdown is not a warning. It is legal cover. A consumer at a gas station register, seeing a pink cartoon bottle, never sees this text.
Commentary
💡 Explore Corporate Misconduct by Category
Corporations harm people every day — from wage theft to pollution. Learn more by exploring key areas of injustice.
- 💀 Product Safety Violations — When companies risk lives for profit.
- 🌿 Environmental Violations — Pollution, ecological collapse, and unchecked greed.
- 💼 Labor Exploitation — Wage theft, worker abuse, and unsafe conditions.
- 🛡️ Data Breaches & Privacy Abuses — Misuse and mishandling of personal information.
- 💵 Financial Fraud & Corruption — Lies, scams, and executive impunity.